10-K

Company

BioRestorative Therapies, Inc.

Filed

March 26, 2026

Period of Report

December 31, 2025

Accession Number

0001493152-26-012925

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →